Cover Image

Malignant Bowel Obstruction - What are the options

VIJAYAN P S PURUSHOTHAMAN

Abstract


Title. Malignant bowel obstruction - what are the options Introduction. Malignant bowel obstruction is a  complication of patients with advanced intra-abdominal and pelvic malignancy with a prevalence of 3-5. Most often in view of the advanced nature of this disease these patients are either not treated or treated conservatively. Nutrition is a  major factor in improving the life expectancy and the quality of life in these patients. If obstruction is mechanical in nature then surgical treatment should be considered as it is proven to be beneficial in 90 of the times. Case description. We  present a 62 year old female with diabetes mellitus, hypertension and rheumatic heart disease who had left MRM for carcinoma breast in 2002, mitral valve replacement,  permanent pace maker placement for RHD in 2009, and TAH, BSO and pelvic nodal dissection for ovarian carcinoma in 2010. She also received 12 cycles chemotherapy following the last operation. She at present came with malignant bowel obstruction with disseminated intra-abdominal malignancy. We relieved her symptoms surgically by doing right   hemicolectomy and ileo-transverse anastomosis despite the disseminated disease and multiple co-morbid illnesses.   Discussion. Malignant bowel obstruction can be due to  functional or mechanical cause. If mechanical in nature then surgical correction is the mainstay of treatment provided the benefit outweighs the risks involved. However this may not be feasible in every patient and in such conditions endo-luminal palliation or pharmacological palliation is to be considered. Restoration of nutrition and there by improving the quality of life and life expectancy should be the ultimate goal.


Full Text:

PDF

References


Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer Oxf Engl 1990. 2008 May;44(8):1105–15.

Tuca A, Guell E, Martinez-Losada E, Codorniu N. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res. 2012 Jun 13;4:159–69.

Blair SL, Chu DZ, Schwarz RE. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol. 2001 Sep;8(8):632–7.

Anthony T, Baron T, Mercadante S, Green S, Chi D, Cunningham J, et al. Report of the Clinical Protocol Committee: Development of Randomized Trials for Malignant Bowel Obstruction. J Pain Symptom Manage. 2007 Jul;34(1):S49–S59.

Bennett MI, Livingstone HJ, Costello P, Allen KR, Degg TJ. Symptom scores, serotonin and 5- hydroxyindole acetic acid levels in cancer patients with and without bowel obstruction. Palliat Med. 2007 Mar;21(2):157–9.

Goyal RK, Hirano I. The enteric nervous system. N Engl J Med. 1996 Apr 25;334(17):1106–15.

Thompson WM, Kilani RK, Smith BB, Thomas J, Jaffe TA, Delong DM, et al. Accuracy of abdominal radiography in acute small-bowel obstruction: does reviewer experience matter? AJR Am J Roentgenol. 2007 Mar;188(3):W233–238.

Soriano A, Davis MP. Malignant bowel obstruction: Individualized treatment near the end of life. Cleve Clin J Med. 2011 Mar 1;78(3):197–206.

Yazdi GP, Miedema BW, Humphrey LJ. High mortality after abdominal operation in patients with large-volume malignant ascites. J Surg Oncol. 1996;62(2):93–6.

Zoetmulder FA, Helmerhorst TJ, van Coevorden F, Wolfs PE, Leyer JP, Hart AA. Management of bowel obstruction in patients with advanced ovarian cancer. Eur J Cancer Oxf Engl 1990. 1994;30A(11):1625–8.

Dy SM. Enteral and parenteral nutrition in terminally ill cancer patients: a review of the literature. Am J Hosp Palliat Care. 2006 Nov;23(5):369–77.

Mohamed F, Cecil T, Moran B, Sugarbaker P. A new standard of care for the management of peritoneal surface malignancy. Curr Oncol Tor Ont. 2011 Apr;18(2):e84–96.

Kato T, Lobritto SJ, Tzakis A, Raveh Y, Sandoval PR, Martinez M, et al. Multivisceral Ex Vivo Surgery for Tumors Involving Celiac and Superior Mesenteric Arteries. Am J Transplant. 2012;12(5):1323–8.

Tassinari D, Maltoni M. Quality of life in palliative care. J Med Pers. 2009 May 1;7(1):11–8. 15. Hisanaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M, et al. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction. Jpn

J Clin Oncol. 2010 Aug;40(8):739–45.

Ripamonti C, Mercadante S. How to use octreotide for malignant bowel obstruction. J Support Oncol. 2004 Aug;2(4):357–64.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University